Group III included proteins with significantly increased levels in PLCH vs SR-ILD, such as proinflammatory chemokines, as Oncostatin M (OSM), Fibroblast growth factor-(FBP)-6 and IFN-γ–induced protein (IP)-10/CXCL10. This evidence concerns the gene OSM and interstitial lung disease.